Development of novel passive sampling devices for ammonia monitoring. This project will develop novel inexpensive passive samplers for ammonia which is an indicator for faecal contamination in stormwater. These devices will increase dramatically the efficiency in isolating intermittent faecal contamination sources in drainage networks by eliminating the need for extensive manual sampling and inspection operations.
Rare Earth Metal Separation by Polymer Inclusion Membranes. The project aims to develop a novel hydrometallurgical method for the separation of the rare earth metals dysprosium and terbium from mixed rare earth metal solutions using polymer inclusion membranes with a crosslinked or non-crosslinked polymer backbone. These metals are crucial for the manufacturing of advanced technology products. The membrane-based method is expected to offer significant advantages over the currently used solvent e ....Rare Earth Metal Separation by Polymer Inclusion Membranes. The project aims to develop a novel hydrometallurgical method for the separation of the rare earth metals dysprosium and terbium from mixed rare earth metal solutions using polymer inclusion membranes with a crosslinked or non-crosslinked polymer backbone. These metals are crucial for the manufacturing of advanced technology products. The membrane-based method is expected to offer significant advantages over the currently used solvent extraction methods by eliminating the use of solvents and conducting the separation as a continuous process where the extraction and back-extraction steps take place simultaneously. These advantages are expected to make the separation process more cost-effective and drastically reduce its environmental impact.Read moreRead less
Environmentally Sustainable Solvents for Natural Pharmaceutical Extraction Processes. Australia supplies 25 per cent of the world's pain relieving medicinal opiates which contributes to a $200 million export industry for Australia. The active pharmaceutical ingredients are extracted and purified at GlaxoSmithKline’s (GSK) Port Fairy processing plant using a solvent extraction based process. Together with GSK the project team aim to examine the use of environmentally sustainable bio-derived natur ....Environmentally Sustainable Solvents for Natural Pharmaceutical Extraction Processes. Australia supplies 25 per cent of the world's pain relieving medicinal opiates which contributes to a $200 million export industry for Australia. The active pharmaceutical ingredients are extracted and purified at GlaxoSmithKline’s (GSK) Port Fairy processing plant using a solvent extraction based process. Together with GSK the project team aim to examine the use of environmentally sustainable bio-derived natural solvents to replace the volatile organic compound (VOC) fossil fuels based solvents used in the current process. Due to environmental and health concerns associated with VOCs the development of alternative solvents will be of great benefit to not only GSK but a range of other processing industries that also use VOC based solvent extraction processes.Read moreRead less
Development of nanoporous materials for capture and release of oxygen. This project aims to develop new materials to make lighter, more efficient oxygen concentrators. The project will combine materials that can capture oxygen with particles that can be magnetically heated, making it possible to release the oxygen rapidly and efficiently when needed. Expected outcomes from this project include new composite materials and better understanding of how gases are trapped and released within composite ....Development of nanoporous materials for capture and release of oxygen. This project aims to develop new materials to make lighter, more efficient oxygen concentrators. The project will combine materials that can capture oxygen with particles that can be magnetically heated, making it possible to release the oxygen rapidly and efficiently when needed. Expected outcomes from this project include new composite materials and better understanding of how gases are trapped and released within composite materials. Benefits from this project may include oxygen concentrators that are more portable and have longer battery life, both with industrial and medical applications.Read moreRead less
Pore Engineering of Chromatography Membranes for Bioseparation. Protein separation and purification is an essential unit operation in manufacturing processes of therapeutic proteins. The project aims to advance the practical applications of chromatography membrane, an emerging technology for protein separation and purification, by tailoring membrane pore geometry and surface functionality to achieve enhanced separation performance. The project expects to generate advanced knowledge and technique ....Pore Engineering of Chromatography Membranes for Bioseparation. Protein separation and purification is an essential unit operation in manufacturing processes of therapeutic proteins. The project aims to advance the practical applications of chromatography membrane, an emerging technology for protein separation and purification, by tailoring membrane pore geometry and surface functionality to achieve enhanced separation performance. The project expects to generate advanced knowledge and techniques in the fields of reactive polymer synthesis, functional membrane fabrication and application in bioseparation. The innovative membranes developed in the project are able to improve the production capacity of therapeutic protein manufacturing processes, providing significant economic benefits to Australia.Read moreRead less
Carbon Molecular Sieve Membranes for Organic Solvent Separation. Directly addressing the pressing challenge of organic solvent separation faced by numerous industries, the project aims to develop molecular sieve membranes with outstanding selectivity and solvent tolerance by constructing zeolite-carbon mixed matrix membrane via incorporating zeolite nanosheets into carbon materials. The project expects to generate advanced knowledge of nanosheet synthesis, membrane fabrication and selective mole ....Carbon Molecular Sieve Membranes for Organic Solvent Separation. Directly addressing the pressing challenge of organic solvent separation faced by numerous industries, the project aims to develop molecular sieve membranes with outstanding selectivity and solvent tolerance by constructing zeolite-carbon mixed matrix membrane via incorporating zeolite nanosheets into carbon materials. The project expects to generate advanced knowledge of nanosheet synthesis, membrane fabrication and selective molecule transport. The membranes developed in the project have great potentials for improving the production capacity and sustainability of Australian industries, e.g., pharmaceutical manufacturing, bioethanol production and petroleum refining, providing significant economic and environmental benefits to Australia.Read moreRead less
Crystal engineering of membranes for chiral separation . This project addresses the urgent challenge of chiral separation in the manufacturing of pharmaceuticals and agrochemicals by creating a new class of membranes produced by engineering functionalised porous framework crystals. This project expects to generate new knowledge regarding how membrane chemistry and architecture can be used to achieve highly selective, fast chiral molecule transport. The expected outcomes of the project include ne ....Crystal engineering of membranes for chiral separation . This project addresses the urgent challenge of chiral separation in the manufacturing of pharmaceuticals and agrochemicals by creating a new class of membranes produced by engineering functionalised porous framework crystals. This project expects to generate new knowledge regarding how membrane chemistry and architecture can be used to achieve highly selective, fast chiral molecule transport. The expected outcomes of the project include new membrane compositions, design principles, fabrication techniques, and proof-of-concept production of scalable, high-performance composite membranes. This project should produce significant economic and environmental benefits in the development of advanced membranes, pharmaceuticals, and agrochemicals.Read moreRead less
Optimisation of nutrient removal, membrane fouling and sludge dewatering in hybrid coagulation/submerged membrane bioreactor treatment of wastewaters. Submerged membrane bioreactor technology for the treatment of wastewaters is now a competitive technology with small footprint and generally high quality of treated effluent. Despite this, challenges remain in ensuring low effluent nutrient concentrations, minimal membrane fouling and acceptable excess sludge dewaterability. Addition of iron or a ....Optimisation of nutrient removal, membrane fouling and sludge dewatering in hybrid coagulation/submerged membrane bioreactor treatment of wastewaters. Submerged membrane bioreactor technology for the treatment of wastewaters is now a competitive technology with small footprint and generally high quality of treated effluent. Despite this, challenges remain in ensuring low effluent nutrient concentrations, minimal membrane fouling and acceptable excess sludge dewaterability. Addition of iron or aluminium-based coagulant chemicals can assist but many uncertainties with regard to choice of chemical, optimal dosing arrangements and membrane bioreactor operating conditions remain. Experimental and computational studies targeted at improving understanding and optimising performance will be undertaken through collaborative studies by the UNSW and Tsinghua University (Beijing) research team.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE140100085
Funder
Australian Research Council
Funding Amount
$300,000.00
Summary
Micro/Nanofluidic Characterisation Facility. Micro/nanofluidic characterisation facility: Microfluidics promises to enable diagnosis of medical diseases using devices which perform laboratory experiments but on a scale which means the entire system can be hand-held. Whilst the fabrication of miniaturised fluidic channels is well established, the challenge is to bring additional functions onto the chip reducing the reliance on external pumps and electronics. This facility will allow the character ....Micro/Nanofluidic Characterisation Facility. Micro/nanofluidic characterisation facility: Microfluidics promises to enable diagnosis of medical diseases using devices which perform laboratory experiments but on a scale which means the entire system can be hand-held. Whilst the fabrication of miniaturised fluidic channels is well established, the challenge is to bring additional functions onto the chip reducing the reliance on external pumps and electronics. This facility will allow the characterisation of technologies which address on-chip sample preparation using pulsed ultrasonic waves, filtration and pumping using nanofluidic structures, and detection using on-chip circuitry. As such the facility will have the capability to directly address the challenges which must be met to allow diagnosis in rural underprivileged areas. Read moreRead less
Highly Efficient Nanomotors for Autonomous Cell Recognition and Isolation. This project aims to develop next-generation self-driven nanomotors capable of long-range motion with highly controlled directionality for cell recognition, transportation and separation in complex biological environments, to allow autonomous and seamless cell sorting with high accuracy. The anticipated goal of this project is to advance the field of nanotechnology and advanced manufacturing with potential to support new ....Highly Efficient Nanomotors for Autonomous Cell Recognition and Isolation. This project aims to develop next-generation self-driven nanomotors capable of long-range motion with highly controlled directionality for cell recognition, transportation and separation in complex biological environments, to allow autonomous and seamless cell sorting with high accuracy. The anticipated goal of this project is to advance the field of nanotechnology and advanced manufacturing with potential to support new applications and to value-add Australia’s advanced manufacturing industry, presenting new opportunities for Australian MedTech industries with innovative, disruptive technologies to address its unique needs and to claim Australia’s position within the competitive global market.Read moreRead less